ArticleBMC medicine2026
Association between maternal preconception blood pressure and spontaneous abortion: a population-based cohort study in China.
Article in BMC medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundMaternal preconception blood pressure (BP) is associated with various adverse pregnancy outcomes, but its relationship with spontaneous abortion (SA) remains controversial. We aimed to evaluate the relationship between preconception BP and SA.
methodsThis population-based cohort study used data from participants in the National Free Preconception Examination Program between 2013 and 2019. Maternal preconception BP was categorized according to the 2017 ACC/AHA guidelines. The relationship between these BP categories and SA incidence was analyzed using multivariable logistic regression to generate adjusted odds ratios (aORs) with 95% confidence intervals (CIs). Additionally, restricted cubic splines were employed to assess the dose-response relationship between maternal BP and the risk of SA.
resultsThe study included 7 067 998 women, of whom 208 508 (2.95%) experienced a SA. Maternal preconception elevated BP (aOR, 1.02; 95% CI: 1.00-1.05), stage 1 hypertension (aOR, 1.06; 95% CI: 1.04-1.08), and stage 2 hypertension (aOR, 1.25; 95% CI: 1.20-1.31) were all associated with an increased risk of SA, demonstrating a gradient relationship. Our results also show that there is a "J"-shaped dose-response relationship between maternal preconception BP and the risk of SA, with the lowest risk observed at a systolic BP of 110 mm Hg and a diastolic BP of 70 mm Hg. Sensitivity analyses excluding individuals with hypotension or self-reported hypertension yielded results consistent with the main analysis.
conclusionsPreconception elevated BP and stage 1 hypertension were associated with an increased risk of SA, although the strength of these associations was weaker than that observed for stage 2 hypertension. There was a "J"-dose-response relationship between maternal preconception BP and the risk of SA, with the lowest risk of SA at systolic BP of 110 mm Hg and diastolic BP of 70 mm Hg.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.